Resources/
Phil Blog
Phil Blog
Meet Nicole Grycan, VP Commercialization at Phil
We are thrilled to have our VP of Commercialization, Nicole Grycan, share her personal journey with us in our next employee spotlight. Nicole’s industry expertise is instrumental in our mission to help people get their medications quickly, easily, and affordably. Tell me a little bit about yourself and what you do at Phil
The Evolving Role of Retail Pharmacies: What Branded Retail and Specialty-Lite Manufacturers Need to Know
Branded retail and specialty-lite pharmaceutical manufacturers must be acutely aware of the changes occurring within the retail pharmacy channel because they directly impact access and commercialization efforts. The evolving landscape – marked by the transition of retail pharmacies into primary care providers, the reduction of chain pharmacy footprints, the rise of mail order and online pharmacies, and critical labor shortages – directly influences how branded prescription medications are distributed, accessed, and managed. The following retail pharmacy trends are strong indicators that manufacturers must consider and adopt an alternative channel strategy in 2024 and beyond
5 Trends Set to Impact Patient Access to Prescription Therapy in 2024
The pharmaceutical industry finds itself at the crossroads of innovative treatments and technological advancements redefining how patients access prescribed therapy. However, this tremendous innovation has also presented unique challenges in securing patient affordability and access to therapy. These five key trends should be considered and will influence how manufacturers should think about shaping their services programs heading into 2024
Is your Patient Access Hub a Strategic Partner?
By Kelly Green, Vice President of Client Success at Phil, Inc. For patients prescribed a specialty or specialty-lite medication, getting started and staying on that therapy is typically a complex and expensive journey. That’s why many life science brands are increasingly turning to hub providers to support patient access and affordability
Digital Health’s Role in Transforming How Healthcare is Delivered
Editor’s Note: As the healthcare ecosystem continues to undergo significant digital transformations, life sciences companies would be wise to consider the impact of this evolution on one of their most important stakeholders - health care providers (HCPs). The fusion of the increased prevalence of blended care models, staff shortages, and higher utilization management requirements have resulted in an environment where HCPs find themselves more constrained than ever. This has made it more challenging for life sciences companies to effectively engage providers to ensure that patients can access their therapies
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
